406
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Advanced Glycation Endproducts Stimulate Renal Epithelial Cells to Release Chemokines That Recruit Macrophages, Leading to Renal Fibrosis

, , , , , & show all
Pages 1741-1745 | Received 07 May 2012, Accepted 09 Jun 2012, Published online: 22 May 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tomohiro Mizuno, Waichi Sato, Kazuhiro Ishikawa, Yuki Terao, Kazuo Takahashi, Yukihiro Noda, Yukio Yuzawa & Tadashi Nagamatsu. (2015) Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury. OncoTargets and Therapy 8, pages 1701-1706.
Read now

Articles from other publishers (12)

Jiayi Yan, Xueling Li, Ni Liu, John Cijiang He & Yifei Zhong. (2023) Relationship between Macrophages and Tissue Microenvironments in Diabetic Kidneys. Biomedicines 11:7, pages 1889.
Crossref
Shruti Bhargava, Erik Merckelbach, Heidi Noels, Ashima Vohra & Joachim Jankowski. (2022) Homeostasis in the Gut Microbiota in Chronic Kidney Disease. Toxins 14:10, pages 648.
Crossref
Jonas Laget, Flore Duranton, Àngel Argilés & Nathalie Gayrard. (2022) Renal insufficiency and chronic kidney disease – Promotor or consequence of pathological post-translational modifications. Molecular Aspects of Medicine 86, pages 101082.
Crossref
Shao-Yang Zhao, Huan-Huan Zhao, Yi-Ming Li, Bao-Hua Wang & Sai-Mei Li. (2022) A Study of the Protective Effect of Bushen Huoxue Prescription on Cerebral Microvascular Endothelia Based on Proteomics and Bioinformatics. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-13.
Crossref
Judit Prat-Duran, Estéfano Pinilla, Rikke Nørregaard, Ulf Simonsen & Niels Henrik Buus. (2021) Transglutaminase 2 as a novel target in chronic kidney disease – Methods, mechanisms and pharmacological inhibition. Pharmacology & Therapeutics 222, pages 107787.
Crossref
Maja Kosanović, Alicia Llorente, Sofija Glamočlija, José M. Valdivielso & Milica Bozic. (2021) Extracellular Vesicles and Renal Fibrosis: An Odyssey toward a New Therapeutic Approach. International Journal of Molecular Sciences 22:8, pages 3887.
Crossref
Yun-xia Shao, Qian Gong, Xiang-Ming Qi, Kun Wang & Yong-gui Wu. (2019) Paeoniflorin Ameliorates Macrophage Infiltration and Activation by Inhibiting the TLR4 Signaling Pathway in Diabetic Nephropathy. Frontiers in Pharmacology 10.
Crossref
Ruochen Qi & Cheng Yang. (2018) Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury. Cell Death & Disease 9:11.
Crossref
Navpreet Kaur, Lalit Kishore & Randhir Singh. (2018) Dillenia indica L. attenuates diabetic nephropathy via inhibition of advanced glycation end products accumulation in STZ-nicotinamide induced diabetic rats. Journal of Traditional and Complementary Medicine 8:1, pages 226-238.
Crossref
Yuichiro Izumi, Hideki Inoue, Yushi Nakayama, Koji Eguchi, Yukiko Yasuoka, Naomi Matsuo, Hiroshi Nonoguchi, Yutaka Kakizoe, Takashige Kuwabara & Masashi Mukoyama. (2017) TSS-Seq analysis of low pH-induced gene expression in intercalated cells in the renal collecting duct. PLOS ONE 12:8, pages e0184185.
Crossref
Sandeep K. Mallipattu & Jaime Uribarri. (2014) Advanced glycation end product accumulation. Current Opinion in Nephrology and Hypertension 23:6, pages 547-554.
Crossref
Vivian Soetikno, Wawaimuli Arozal, Melva Louisa & Rianto Setiabudy. (2014) New Insight into the Molecular Drug Target of Diabetic Nephropathy. International Journal of Endocrinology 2014, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.